Thiruvananthapuram: Megasys Biotek Pvt. Ltd., the state-of-the-art pharmaceutical formulation unit at KINFRA Industries Park, Koratty and a subsidiary of Akesiss Pharma Pvt. Ltd., is on an expansion mode. The company is in the process of enhancing its tablet manufacturing capacity to 30 million per month from its current capacity of 12.5 million per month. The plan is to complete the installation of machineries and start production at the new facility by the second quarter of 2017-18 fiscal. A WHO-GMP certified-unit, the manufacturing plant at Megasys Biotek has a built-up area of 25,000 sq.ft. It is equipped with technologically-advanced equipment and automated systems to produce tablets, oral liquids, eye/ear drops and nasal drops. Currently, the plant has the capacity to produce one million bottles of oral liquids and ophthalmic preparations per month. The unit, which began operations in 2011, manufactures and supplies drugs to leading companies in Kerala as well as other states. It also exports products to Sri Lanka in a big way. Megasys recently received orders from Kerala Medical Services Corporation also. The infrastructure has been set up as per current Good Manufacturing Practice guidelines of various international regulatory bodies like United States Food and Drug Administration, Therapeutic Goods Administration of Australia and Medicines and Healthcare Products Regulatory Agency of the UK. Besides, there is heating, ventilation and air conditioning system to ensure ISO standards of air classification. For details, contact, ph: +91 9418714779. Destination KeralaInfrastructure and KINFRAMarch 31, 2017InfrastructureKINFRAMegasys Biotek Pvt. Ltd.